What is the standard of care with regard to these two drugs which each have “Black Box Warnings”? Are we expected to advise every patient to whom we prescribe a fluoroquinolone of the possibility of bone or tendon problems, and every patient to whom we prescribe clindamycin of the risk of C. diff?
One Response to “When to Use Fluoroquinolones in Pediatric Patients”
May 25, 2016
Charles A. Pilcher MD FACEPWhat is the standard of care with regard to these two drugs which each have “Black Box Warnings”? Are we expected to advise every patient to whom we prescribe a fluoroquinolone of the possibility of bone or tendon problems, and every patient to whom we prescribe clindamycin of the risk of C. diff?